ProMIS Neurosciences, Inc. (PMN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.38M | -9.05M | -10.18M | -3.85M | -4.93M | -8.23M | -6.67M | -1.5M | -10.29M | -3.63M | -2.38M | -2.15M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -151.35% | -9.94% | -52.63% | -156.18% | 52.13% | -126.79% | -180.72% | 29.94% | -301.75% | 20.28% | 48.74% | 52.04% |
| Net Income | -8.24M | -39.69B | -11.58M | -10.12M | -7.35M | -238.21K | 9.28M | -2.62M | -3.64M | -3.58M | -2.36M | -2.31M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.02K | 345 | 1.24K |
| Stock-Based Compensation | 0 | 856.97M | 0 | 212.01K | 245.29K | 623.19K | 121.04K | 18K | 63.58K | 0 | 0 | 134.19K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -551.03K |
| Other Non-Cash Items | 189.43K | 38.82B | 75.61K | 0 | 0 | -5.26M | -13.47M | -59.09K | 14.13K | -10.48K | -76.77K | -95.08K |
| Working Capital Changes | -4.33M | 1.47M | 1.32M | 6.05M | 2.18M | -3.36M | -2.59M | 1.16M | -6.73M | -57.42K | 60.61K | 675.34K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -826.59K | -2.34M | 1.45M | 1.58M | -537.3K | 262.16K | -439.93K | 611.58K | -6.44M | -543.77K | 623.92K | 812.89K |
| Cash from Investing | 0 | -703 | 0 | 0 | 0 | -678 | 0 | 0 | 0 | -1.34K | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 701.3K | 0 | 0 | 0 | 692.32K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 70.08M | -277.64K | 21.26M | 0 | 0 | 9.02K | 27.22M | 0 | 190.27K | -748.02K | 18.26M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 70.08M | -380.95K | 21.26M | 0 | 0 | 470K | 27.19M | 0 | 190.27K | -748.02K | 18.26M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 103.32K | 0 | 0 | 0 | -460.98K | 28.04K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 57.7M | -9.28M | 10.89M | -3.85M | -4.93M | -8.25M | 20.54M | -1.5M | -10.1M | -4.27M | 15.65M | -2.11M |
| Free Cash Flow | -12.38M | -9.05M | -10.18M | -3.85M | -4.93M | -8.23M | -6.67M | -1.5M | -10.29M | -3.63M | -2.38M | -2.15M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -151.35% | -9.94% | -52.63% | -156.18% | 52.13% | -126.79% | -180.72% | 29.94% | -301.75% | 20.31% | 48.74% | 52.04% |
| FCF per Share | -1.90 | -5.15 | -7.30 | -2.76 | -3.53 | -5.91 | -5.55 | -1.90 | -13.17 | -4.63 | -4.80 | -6.26 |
| FCF Conversion (FCF/Net Income) | 1.50x | 0.85x | 0.88x | 0.38x | 0.67x | 34.56x | -0.72x | 0.57x | 2.83x | 1.01x | 1.01x | 0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 31 | -31 | 76.78K | 0 | 75.47K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |